Daptomycin Market Share, Trends, Applications and Competitive Landscape Till 2027
Market Highlights
According to MRFR analysis, the Global
Daptomycin Market is expected to register a CAGR of 4.4% during the forecast
period 2020 to 2027 and reach USD 5,122.7 Million by 2027.
Daptomycin is a cyclic lipopeptide
antibiotic derived from the organism Streptomyces rose sports. Daptomycin is
used for the treatment of various bacterial infections caused by gram-positive
bacteria.
The growth of the global Daptomycin Market can be
attributed to the high demand of daptomycin due to rising infections in the
bloodstream, and increasing complicated skin and skin structure infections.
Furthermore, the rise of right-sided
infective endocarditis, and daptomycin as an antibacterial drug, a bacterial
metabolite and a member of calcium-dependent antibiotics, are also expected to
fuel the market growth during the forecast period.
However, increasing rates of infection
with gram-positive bacteria and the rapid emergence of resistance to the new
agent are expected to restrain the growth of the global daptomycin market.
Several market players such as Cipla,
Pfizer, and Dr. Reddy’s Laboratories among others currently dominate the global
daptomycin market.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/10081
Regional Analysis
The market has been divided, by region,
into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The
Americas region held the largest market in 2020, owing to the rising
complicated skin and skin structure infections in the region. The daptomycin
market in the Americas has further been branched into North America and Latin
America, with the North American market divided into the US and Canada. The
European daptomycin market has been categorized as Western Europe and Eastern
Europe. The Western European market has further been classified as Germany,
France, the UK, Italy, Spain, and the rest of Western Europe. The daptomycin
market in Asia-Pacific has been segmented into China, India, Japan, Australia,
South Korea, and the rest of Asia-Pacific. Due to rising infections in the
bloodstream in the region, the market in Asia-Pacific is expected to be the
fastest-growing. The daptomycin market in the Middle East & Africa has been
divided into the Middle East and Africa.
Segmentation
Global Daptomycin Market has been
segmented based on Indication, Age Group, and Strength.
Based on indication, the global
daptomycin market has been segmented into complicated skin structure
infections, bacteremia, and others. The complicated skin structure infections
are expected to be the fastest-growing segment during the forecast period.
Based on the age group, the market has
been segmented into pediatric and adult. The adult segment is expected to hold
the largest market share with an increasing number of bacteremia and
right-sided infective endocarditis patients.
Based on strength, the market is
segmented into 350 mg and 500 mg.
Key Players
Some of the key players in the global
daptomycin market are Teva Pharmaceutical Industries Ltd. (Israel), Merck &
Co (US), Cipla (India), Pfizer (US), BE Pharmaceuticals (US), Dr. Reddy’s
Laboratories (India), Mylan (US), Fresenius Kabi (Germany), Nichi-Iko
Pharmaceutical (Japan), Novo Holdings A/S (Denmark), Zhejiang Hisun (China),
Hengrui Medicine (China), Huadong Medicine (China), Civica Rx (US).
Access Report Details @ https://www.marketresearchfuture.com/reports/daptomycin-market-10081
About Market Research Future:
At Market Research Future (MRFR), we
enable our customers to unravel the complexity of various industries through
our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), &
Consulting Services. MRFR team have supreme objective to provide the optimum
quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
Comments
Post a Comment